CRISPR Therapeutics for Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is an X-linked recessive neuromuscular disorder with a prevalence of approximately 1 in 3500–5000 males. DMD manifests as childhood-onset muscle degeneration, followed by loss of ambulation, cardiomyopathy, and death in early adulthood due to a lack of functional dy...

Descripción completa

Detalles Bibliográficos
Autores principales: Erkut, Esra, Yokota, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836469/
https://www.ncbi.nlm.nih.gov/pubmed/35163754
http://dx.doi.org/10.3390/ijms23031832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836469/
https://www.ncbi.nlm.nih.gov/pubmed/35163754
http://dx.doi.org/10.3390/ijms23031832

Ejemplares similares